🇺🇸 Metronidazole Topical Gel in United States
75 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 75
Most-reported reactions
- Erythema — 16 reports (21.33%)
- Drug Ineffective — 10 reports (13.33%)
- Condition Aggravated — 9 reports (12%)
- Skin Burning Sensation — 9 reports (12%)
- Off Label Use — 6 reports (8%)
- Rash — 6 reports (8%)
- Dry Skin — 5 reports (6.67%)
- Pruritus — 5 reports (6.67%)
- Rosacea — 5 reports (6.67%)
- Dizziness — 4 reports (5.33%)
Frequently asked questions
Is Metronidazole Topical Gel approved in United States?
Metronidazole Topical Gel does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Metronidazole Topical Gel in United States?
Riyadh Elm University is the originator. The local marketing authorisation holder may differ — check the official source linked above.